Efficacy and Safety of Fixed-Dose-Rate Infusions of Gemcitabine Plus Erlotinib for Advanced Pancreatic Cancer. Journal of Analytical Oncology, [S. l.], v. 4, n. 1, p.  44–51, 2015. DOI: 10.6000/1927-7229.2015.04.01.8. Disponível em: https://www.neoplasiaresearch.com/index.php/jao/article/view/242. Acesso em: 7 nov. 2025.